Cardiff MDT

The Cardiff MDT incorporates University Hospital of Wales in Cardiff http://www.cardiffandvaleuhb.wales.nhs.uk/home

View Trust Services

This trust offers the following services:

  • Acute services:
    • Specialist colorectal surgeon on-call at all times
  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
    • On-site thoracic surgical team
    • Robotic surgery
  • Advanced disease services:
    • Distal sacrectomy
    • Extended lymphadenectomy
    • HIPEC/cytoreductive surgery
  • Support service facilities:
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 317 2335 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 96 96 86
– Performance status (%) 96 98 89
Patients having major resection: Trust Network National
Number of patients in Audit 197 1436 19631
ASA grade 1 (%) 9 6 9
ASA grade 2 (%) 50 49 53
ASA grade 3 (%) 17 37 31
ASA grade 4+ (%) 23 7 2
ASA grade not recorded (%) 1 1 4
Data completeness of:
7 Audit items for risk-adjustment (%) 95 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 317 2335 35779
Seen by Clinical Nurse Specialist (%) 95 88 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 197 1436 19614
Distant metastases (%) 8 8 5
Urgent or emergency surgery (%) 16 18 15
At least 12 lymph nodes excised (%) 92 89 84
Laparoscopic surgery attempted (%) 97 65 72
Risk-adjusted length of stay > 5 days (%) 44 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 68 N/A 10747
Adjuvant chemotherapy (%) 49 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 40 N/A 4251
Neoadjuvant therapy (%) 28 N/A 33
Circumferential resection margin: Recorded (%) 95 91 89
Circumferential resection margin: Negative (%) 90 86 83
Rectal volume 38 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 90 1145 19644
APER/Hartmanns (%) 30 45 37

Compare trust outcomes